openPR Logo
Press release

Investors who lost money with shares of 10x Genomics, Inc. (NASDAQ: TXG) should contact the shareholders Foundation in connection with Investigation

02-22-2024 07:05 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Shareholders Foundation

An investigation for investors in 10x Genomics, Inc. (NASDAQ: TXG) shares over potential securities laws violations.

An investigation for investors in 10x Genomics, Inc. (NASDAQ: TXG) shares over potential securities laws violations.

An investigation was announced concerning possible securities laws violations by 10x Genomics, Inc. in connection with certain financial statements.

Investors who purchased shares of 10x Genomics, Inc. (NASDAQ: TXG), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of 10x Genomics, Inc. (NASDAQ: TXG) concerning whether a series of statements by 10x Genomics, Inc. regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

Pleasanton, CA based 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in the America, Europe, the Middle East, Africa, China, and the Asia Pacific. 10x Genomics, Inc. reported that its annual Total Revenue rose from $490.49 million in 2021 to $516.4 million in 2022, and that its Net Loss increased from $58.22 million in 2021 to $166 million in 2022.

Shares of 10x Genomics, Inc. (NASDAQ: TXG) declined from $57.78 per share in late December 2023, to as low as $40.97 per share on January 25, 2024.

Those who purchased shares of 10x Genomics, Inc. (NASDAQ: TXG) have certain options and should contact the Shareholders Foundation.

Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Investors who lost money with shares of 10x Genomics, Inc. (NASDAQ: TXG) should contact the shareholders Foundation in connection with Investigation here

News-ID: 3395956 • Views:

More Releases from Shareholders Foundation

Lawsuit for Investors in Sonder Holdings Inc. (NASDAQ: SOND) filed in effort to recover losses
Lawsuit for Investors in Sonder Holdings Inc. (NASDAQ: SOND) filed in effort to …
An investor, who purchased shares of Sonder Holdings Inc. (NASDAQ: SOND), filed a lawsuit over alleged violations of Federal Securities Laws by Sonder Holdings Inc in connection with certain allegedly false and misleading statements. Investors who purchased shares of Sonder Holdings Inc. (NASDAQ: SOND) have certain options and for certain investors are short and strict deadlines running. Deadline: June 10, 2024. NASDAQ: SOND investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com
Lawsuit filed for Investors in Ocugen, Inc. (NASDAQ: OCGN) in effort to recover losses
Lawsuit filed for Investors in Ocugen, Inc. (NASDAQ: OCGN) in effort to recover …
An investor, who purchased shares of Ocugen, Inc. (NASDAQ: OCGN), filed a lawsuit i over alleged violations of Federal Securities Laws by Ocugen, Inc.. Investors who purchased shares of Ocugen, Inc. (NASDAQ: OCGN) have certain options and for certain investors are short and strict deadlines running. Deadline: June 10, 2024. NASDAQ: OCGN investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. Malvern, PA based Ocugen, Inc., a
Investors who lost money with shares of Evolv Technologies Holdings, Inc. (NASDAQ: EVLV) should contact the Shareholders Foundation in connection with Lawsuit
Investors who lost money with shares of Evolv Technologies Holdings, Inc. (NASDA …
An investor, who purchased shares of Evolv Technologies Holdings, Inc. (NASDAQ: EVLV), filed a lawsuit in the U.S. District Court for the District of Massachusetts over alleged violations of Federal Securities Laws by Evolv Technologies Holdings, Inc. f/k/a NewHold Investment Corp. Investors who purchased shares of Evolv Technologies Holdings, Inc. (NASDAQ: EVLV) have certain options and for certain investors are short and strict deadlines running. Deadline: May 24, 2024. NASDAQ: EVLV
Investigation announced for Investors who purchased shares of Comtech Telecommunications Corp. (NASDAQ: CMTL) over possible Violations of Securities Laws
Investigation announced for Investors who purchased shares of Comtech Telecommun …
Comtech Telecommunications Corp is under investigation over potential securities laws violations in connection with certain financial statements. Investors who purchased shares of Comtech Telecommunications Corp. (NASDAQ: CMTL), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm focuses on whether a series of statements by Comtech Telecommunications Corp. regarding its business, its prospects and its operations were materially false

All 5 Releases


More Releases for Genomics

Spatial Genomics and Transcriptomics Market to Witness Huge Growth by Key Player …
This report provides an informative view about the competitive aspect of the global market. It includes detailed picture of the exhibition of a portion of the essential global players working in the Spatial Genomics and Transcriptomics market. The research study also provides historical record with profits predictions and forecasts from 2022 to 2028. Also, the business manufacturing of the notable manufacturers is also emphasized with technical data in the report. This
Artificial Intelligence for Genomics and Personalised Medicine Market 2021-28|| …
An artificial neural network can reveal patterns in huge amounts of gene expression data, and discover groups of disease-related genes. Scientists hope that the new method can eventually be applied within precision medicine and individualized treatment. Similar to diagnosing a disease using a genomic basis, AI can help identify which genes have been affected by harmful mutations so that they can be targeted in gene therapy. DNA repair after editing is
Artificial Intelligence In Genomics Market have Huge Growth of CAGR 52% By 2021- …
The recent report on the Artificial Intelligence In Genomics market offers a thorough assessment of the business vertical as well as a comprehensive overview of the industry and its key segments. According to the report, the growing technological developments and research advancements are contributing to the market's expansion. The report provides extensive insight into key market elements such as drivers, restraints, challenges, strategic expansions, market size and share, growth prospects,
AI in Genomics Market Top Manufacturers 2030 Fabric Genomics Inc., Verge Genomic …
Allied Market Research published a latest report titled, “AI in Genomics Market : Global Opportunity Analysis and Industry Forecast 2020-2027’’. The market report features the factors and top market trends that fuel the growth of the market. Avail sample report with Industry Insights @ https://www.alliedmarketresearch.com/request-sample/11921 Frontrunners in the AI in Genomics Market: The report includes the frontrunners in the market including Fabric Genomics Inc., Verge Genomics, Freenome Holdings, Inc., MolecularMatch Inc. These market
What's Driving the Spatial Genomics Market Growth? 10x Genomics, S2 Genomics, Na …
This Spatial Genomics Market research document is structured with the most excellent and advanced tools of collecting, recording, estimating and analysing market data. A profound knowledge of industrial unanimity, market trends and incredible techniques give client's an upper hand in the ABC industry. Businesses can effectively use the data, statistics, research, and insights about the market included in this Spatial Genomics Market report to make decisions about business strategies and
Spatial Genomics and Transcriptomics Market Latest Trends and Forecast Analysis …
Los Angeles, United State: QY Research announced the publication of a new research report to its ever-growing repository. It sheds light on the global Spatial Genomics and Transcriptomics market. The research report is collated using primary and secondary research methodologies to provide the users with a precise analysis of the market dynamics. Analysts have used SWOT analysis and Porter's five forces analysis for providing the readers with a detailed understanding